RecruitingNCT05459597

Antiepileptic Drugs in Elderly Patients

Population Pharmacokinetics, Effectiveness and Safety of Antiepileptic Drugs in Elderly Patients

Sponsor

Wei Zhao

Enrollment

500 participants

Start Date

Jan 1, 2021

Study Type

OBSERVATIONAL

Conditions

Seizure, Epileptic

Summary

The purpose is to study the population pharmacokinetics, effectiveness and safety of antiepileptic drug (phenytoin, carbamazepine, lamotrigine, levetiracetam, parempanel, etc) in elderly patients and recommend optimized dosage regimens.

Eligibility

Min Age: 65 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying antiepileptic drugs for people with seizure, epileptic. The study is currently recruiting participants at 1 location. People eligible for this study include aged 65 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGantiepileptic drugs

phenytoin, carbamazepine, lamotrigine, levetiracetam, perampanel, etc. as part of routine treatment.

Locations(1)

Wei Zhao

Jinan, Shandong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05459597

Related Trials

Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure

NCT068366871 location